Context Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CEOMartin A. Lehr
CEOMartin A. Lehr
Employees12
Employees12
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2015
Founded2015
Employees12
Employees12
CNTX Key Statistics
Market cap58.34M
Market cap58.34M
Price-Earnings ratio-1.92
Price-Earnings ratio-1.92
Dividend yield—
Dividend yield—
Average volume169.33K
Average volume169.33K
High today$0.6796
High today$0.6796
Low today$0.6213
Low today$0.6213
Open price$0.652
Open price$0.652
Volume87.22K
Volume87.22K
52 Week high$2.75
52 Week high$2.75
52 Week low$0.49
52 Week low$0.49
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CNTX. This list is generated using Robinhood data, and it’s not a recommendation.